Last reviewed · How we verify
NCT06060951: RAPPER
Relating Abdominal Complications With Peritoneal Pressure Estimation and Reporting
trial testing Estimated intraperitoneal pressure in Peritoneal Dialysis in 300 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Imperial College Healthcare NHS Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 October 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 July 2025 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Estimated intraperitoneal pressure
Conditions studied
- Peritoneal Dialysis — all drugs for Peritoneal Dialysis →
- Kidney Failure, Chronic — all drugs for Kidney Failure, Chronic →
- Hernia, Abdominal — all drugs for Hernia, Abdominal →
Sponsor
Imperial College Healthcare NHS Trust
Who can join
18 and older, any sex, with Peritoneal Dialysis or Kidney Failure, Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective observational study in people treated with peritoneal dialysis for kidney failure to investigate whether estimated intraperitoneal pressure (eIPP) is correlated with non-infectious PD-related complications in end-stage renal failure patients. It looks to understand how both peritoneal dialysis complications (including fluid leaks and hernias) along with gastrointestinal symptoms are associated with eIPP in people treated with PD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06060951
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peritoneal Dialysis
Currently open trials in the same condition.
- NCT07098351 — Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis · NA · recruiting
- NCT07077538 — Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients · NA · recruiting
- NCT06876987 — The Mobile-based Training System in Peritoneal Dialysis Patients · NA · recruiting
- NCT06641765 — Continuous Glucose Monitoring in Dialysis Patients With Diabetes · NA · active not recruiting
- NCT06368713 — Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients · NA · recruiting
Other Imperial College Healthcare NHS Trust trials
Trials by the same sponsor.
- NCT07474584 — OpRESTORE AI-Patient Navigator Study · NA · not yet recruiting
- NCT07191678 — Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions · recruiting
- NCT06501846 — Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding. · NA · recruiting
- NCT04904484 — A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients · NA · unknown
- NCT06355570 — Delirium After Cardiac Surgery in Intensive Care Units · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06060951 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Imperial College Healthcare NHS Trust
- Last refreshed: 29 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06060951.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing